Axcella Health

General Information

We are a biotechnology company pioneering the research and development of novel multifactorial interventions to support health and address dysregulated metabolism across a broad spectrum of consumers and patients who have limited options. Our AXA Candidates are generated from our proprietary, human-focused AXA Development Platform and harness the power of endogenous metabolic modulators, or EMMs, a broad family of molecules that fundamentally impact and regulate human metabolism.

Employees: 49
Founded: 2008
Contact Information
Address 840 Memorial Drive, Cambridge, MA 02139, US
Phone Number (857) 320-2200
Web Address
View Prospectus: Axcella Health
Financial Information
Market Cap $459.8mil
Revenues $0 mil (last 12 months)
Net Income $-36.1 mil (last 12 months)
IPO Profile
Symbol AXLA
Exchange NASDAQ
Shares (millions): 3.6
Price range $20.00 - $20.00
Est. $ Volume $71.4 mil
Manager / Joint Managers Goldman Sachs/ J.P. Morgan/ SVB Leerink
CO-Managers -
Expected To Trade: 5/9/2019
Status: Priced
Quiet Period Expiration Date:
Lock-Up Period Expiration Date:
SCOOP Rating
Rating Change